Plain-English translation of NCT07908888 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a treatment combination called combined with and lower doses of traditional chemotherapy drugs works well and is safe for older adults or frail patients with newly diagnosed diffuse large B-cell lymphoma. The idea behind this research is to use lower doses of the harsh chemotherapy drugs while adding newer, more targeted medications that may work better with fewer side effects. Researchers want to see if this gentler approach can help patients stay cancer-free while being easier to tolerate.
Older and frail patients with this type of lymphoma have traditionally been treated with standard chemotherapy that can be very hard on their bodies. This trial exists to find out whether combining this newer medication with reduced doses of chemotherapy might be safer and still effective for patients who might not tolerate the standard, full-strength treatment.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive the medication combination intravenously (through an IV) in six 3-week cycles, followed by two additional cycles of one of the drugs alone as a consolidation phase. This means you will visit the clinic regularly over approximately five to six months for infusions, blood tests, and check-ups. Your doctors will monitor you closely for side effects and effectiveness throughout the treatment and continue to follow your progress after the treatment ends.
AI-generated summary from trial data · Nov 3, 2026 · Not medical advice
China